Table 1.
Ref. | Case/control | Peroxidation | TAC | Inflammation | Lipid profile |
---|---|---|---|---|---|
[18] | 100/100 | ↑ MDA | ↑ CHOL, LDL | ||
↔ HDL, TG | |||||
[19] | 100/100 | ↑ MDA | ↑VAP-1 | ↑ CHOL, LDL | |
↔ HDL, TG | |||||
[20] | 25/20: 10/10 smokers | ↑ MDA | |||
15/10 non-smokers | ↑ MDA | ||||
[21] | 29/18 | ↑MDA/TBARS | ↓ | ↑ROS | |
[22] | 30/10: 10 mild | ↔ | |||
10 moderate | ↔ | ||||
10 severe | ↔ | ||||
[23] | 35/25 | ↑ MDA | ↓ | ||
[24] | 32/32 | ↑ MDA | |||
[25] | 8/8 | ↑ peroxides | ↓ | ||
[26] | 34/37 | ↑ TBARS, oxLDL | ↔ | ↑ CRP | ↑ CHOL, LDL, TG |
↓ HDL | |||||
[27] | 73/38 | ↑ TBARS | ↔ | ↑CRP | |
[28] | 67/35 | ↑ TBARS | |||
[29] | 58/45 | ↑ MDA | ↓ | ||
[30] | 54/62: 28/16 smokers | ↑ TOS | ↓ | ↔ CHOL, LDL, HDL, TG | |
26/46 non-smokers | ↑ TOS | ↓ | ↔ CHOL, LDL, HDL, TG | ||
[31] | 23/25: 12 mild (1) | ↑ peroxides and dienes | ↔ CRP | ↔ CHOL, LDL, HDL, TG | |
11 severe (2) | ↑ peroxides and dienes | ↔ CRP | ↔ CHOL, LDL, HDL, TG | ||
[32] | 55/20: 11 mild, | ↑ MDA | ↓ | ||
20 moderate | ↑ MDA | ↓ | |||
24 severe | ↑ MDA | ↓ | |||
[33] | 7/6 | ↑ | |||
[34] | 16/16 | ↑ TBARS | ↓ | ||
[35] | 59/40 | ↑ MDA | ↑ IL-6 | ||
[36] | 90/30: 30 mild | ↑ MDA | ↓ | ||
30 moderate | ↑ MDA | ↓ | |||
30 severe | ↑ MDA | ↓ | |||
[37] | 39/25 | ↑ TOC | ↓ | ||
[38] | 60/47 | ↑ peroxides | ↓ | ||
[39] | 32/20 | ↔ TBARS | |||
[40] | 40/20 | ↑ peroxides | |||
[41] | 127/389 | ↑ peroxides | |||
[42] | 100/100: 29 Mild | ↑ MDA | ↑ CHOL, LDL | ||
↔ HDL, TG | |||||
60 Moderate | ↑ MDA | ↑ CHOL, LDL | |||
↔ HDL, TG | |||||
11 Severe | ↑ MDA | ↑ CHOL, LDL | |||
↔ HDL, TG | |||||
[43] | ↑ CHOL, TG | ||||
30/33 | ↑ oxLDL | ↑ ESR | ↔ LDL | ||
↓ HDL | |||||
[44] | 24/26 | ↑ MDA | ↑ IL-8 | ||
[45] | 90/90: 30 mild | ↑ MDA | |||
30 moderate | ↑ MDA | ||||
30 severe | ↑ MDA | ||||
[46] | 40/40: 34 remission | ↔ MDA | |||
6 acute | ↑ MDA | ||||
[47] | 60/30: 30 inactive psoriasis | ↑ TBARS | ↓ | ↔CHOL, LDL, TG | |
↓ HDL | |||||
30 active psoriasis | ↑ TBARS | ↓ | ↑ CHOL, LDL, TG ↓ HDL | ||
[48] | 60/40: 30 inactive psoriasis | ↑ TBARS | ↔ | ↑ CRP | |
30 active psoriasis | ↑ TBARS | ↓ | ↑ CRP | ||
[49] | 48/40: 24 inactive psoriasis | ↑ TBARS | ↔ | ↔CHOL, LDL, TG | |
↓ HDL | |||||
24 active psoriasis | ↑ TBARS | ↓ | ↑ CHOL, LDL, TG ↓ HDL | ||
[50] | 33/36 | ↔ | |||
[51] | 23/23 | ↑ MDA | |||
[52] | 45/45 | ↑ MDA | ↑ CHOL, LDL, ↔ HDL, TG | ||
[53] | 40/47 | ↑ TOS | ↓ | ||
[54] | 30/23 | ↔ MDA | ↔ | ↔ CHOL, LDL, HDL, TG | |
[55] | 52/25: 25 with MS | ↔ TOS | ↔ | ↑ CHOL, LDL, TG | |
↓ HDL | |||||
27 without MS | ↔ TOS | ↔ | ↔ CHOL, LDL, HDL, TG | ||
[56] | 35/35 | ↑ MDA, oxLDL | ↓ | CRP, ESR↑ | ↑ CHOL, LDL, TG ↓ HDL |
[57] | 67/35 | ↑ TBARS | |||
[58] | 22/22 | ↔ MDA |
CHOL: cholesterol; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; HDL: high-density lipoprotein; IL: interleukin; LDL: low-density lipoprotein; MDA: malondialdehyde; MS: metabolic syndrome; oxLDL: oxidized low-density lipoprotein; ROS: reactive oxygen species; TAC: total antioxidant capacity; TBARS: thiobarbituric acid reactive substance; TG: triglycerides; TOC: total oxidant capacity, also named total oxidant status (TOS); VAP-1: vascular adhesion protein-1; ↑: increased; ↓: decreased; ↔: unchanged